These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25708281)

  • 1. Clinical outcomes of intravenous immunoglobulin therapy in refractory uveitis.
    Garcia-Geremias M; Carreño E; Epps SJ; Lee RW; Dick AD
    Int Ophthalmol; 2015 Apr; 35(2):281-5. PubMed ID: 25708281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravenous immunoglobulin treatment in refractory uveitis.
    Onal S; Foster CS; Ahmed AR
    Ocul Immunol Inflamm; 2006 Dec; 14(6):367-74. PubMed ID: 17162608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis.
    Moretti M; Buiatti A; Merlo M; Massa L; Fabris E; Pinamonti B; Sinagra G
    Am J Cardiol; 2013 Nov; 112(9):1493-8. PubMed ID: 23972350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.
    Mesquida M; Molins B; Llorenç V; Sainz de la Maza M; Adán A
    Ophthalmology; 2014 Dec; 121(12):2380-6. PubMed ID: 25204610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis.
    Raja J; Nihtyanova SI; Murray CD; Denton CP; Ong VH
    Rheumatology (Oxford); 2016 Jan; 55(1):115-9. PubMed ID: 26320139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report.
    Foster CS; Chang PY; Ahmed AR
    Ophthalmology; 2010 May; 117(5):861-9. PubMed ID: 20045562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsed intravenous immunoglobulin therapy in refractory ulcerated livedoid vasculopathy: seven cases and a literature review.
    Kim EJ; Yoon SY; Park HS; Yoon HS; Cho S
    Dermatol Ther; 2015; 28(5):287-90. PubMed ID: 25845419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.
    Cherin P; Pelletier S; Teixeira A; Laforet P; Genereau T; Simon A; Maisonobe T; Eymard B; Herson S
    Arthritis Rheum; 2002 Feb; 46(2):467-74. PubMed ID: 11840450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of refractory uveitis with intravenous immunoglobulin.
    Rosenbaum JT; George RK; Gordon C
    Am J Ophthalmol; 1999 May; 127(5):545-9. PubMed ID: 10334347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective case review of pediatric patients with uveitis treated with infliximab.
    Rajaraman RT; Kimura Y; Li S; Haines K; Chu DS
    Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
    Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events.
    Seidling V; Hoffmann JH; Enk AH; Hadaschik EN
    Acta Derm Venereol; 2013 May; 93(3):346-9. PubMed ID: 23073990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis-An Interventional Case Series.
    Steger B; Madhusudan S; Kaye SB; Stylianides A; Romano V; Maqsood SE; Harper J; Ahmad S
    Cornea; 2016 Dec; 35(12):1611-1614. PubMed ID: 27661067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
    Ogata S; Ogihara Y; Honda T; Kon S; Akiyama K; Ishii M
    Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis.
    Maca SM; Abela-Formanek C; Kiss CG; Sacu SG; Benesch T; Barisani-Asenbauer T
    Clin Exp Ophthalmol; 2009 May; 37(4):389-96. PubMed ID: 19594566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disorders.
    Broyles R; Rodden L; Riley P; Berger M
    Postgrad Med; 2013 Mar; 125(2):65-72. PubMed ID: 23816772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
    Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
    Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose intravenous immunoglobulin (IVIg) in severe refractory rheumatoid arthritis: no evidence for efficacy.
    Maksymowych WP; Aviña-Zubieta A; Luong M; Russell AS
    Clin Exp Rheumatol; 1996; 14(6):657-60. PubMed ID: 8978962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Immunoglobulin Therapy in Refractory Autoimmune Dysautonomias: A Retrospective Analysis of 38 Patients.
    Schofield JR; Chemali KR
    Am J Ther; 2019; 26(5):570-582. PubMed ID: 29781817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.